Communiqués Demant A/S Berne S.E.

Actions

Temps Différé Berne S.E. Autres places de cotation 18:00:03 15/11/2023			Varia. 5j.	Varia. 1 janv.
34,92 ^CHF	-.--%		-19,92 %	-6,81 %

26/06	Demant signale un retard dans l'achèvement de la revue stratégique de son activité de communication	MT
29/05	L'autorite britannique de regulation de la concurrence met fin a l'operation Cochlear-Demant	MT

Demant A/S: Updated timeline for the strategic review of Communications	26/06	AQ
Demant A/S: Closing of divestment of cochlear implants business	21/05	AQ
Demant A/S: Interim Management Statement for Q1 2024	06/05	AQ
Demant A/S: Completion of capital reduction in Demant A/S	08/04	AQ
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare	12/03	AQ
Demant A/S: Decisions of Annual General Meeting	06/03	AQ
Demant A/S: Transactions with Demant shares by Board of Directors and Executive Board and closely related parties	28/02	AQ
Demant A/S: Notice of annual general meeting	07/02	AQ
Demant A/S: Annual Report 2023 (zip file)	06/02	AQ
Demant A/S: Annual Report 2023	06/02	AQ
Demant A/S: Results for 2023 and outlook for 2024	05/02	AQ
Demant A/S: Review of strategic options for Communications	05/02	AQ
Demant A/S: Transactions with Demant shares by managers and closely related parties	10/01	AQ
Demant A/S: New Head of Investor Relations	03/01	AQ
Demant A/S: Financial calendar 2024	11/12	AQ
Demant A/S: Demant to resume share buy-backs	21/11	AQ
Demant A/S: Investor news - Demant Capital Markets Day 2024	10/11	PU
Demant A/S: Investor news - Demant Kapitalmarkedsdag 2024	10/11	PU
Demant A/S: Investor news - Demant Capital Markets Day 2024	08/11	AQ
Demant A/S: Interim Management Statement for Q3 2023	07/11	AQ

Aucun résultat pour cette recherche

DEMANT : Baisse du chiffre d'affaires au 1er trimestre ; prévisions de croissance organique inchangées

Le 06 mai 2024 à 17:18